Hongyun Bio

Hongyun Bio

红云生物

Hongyun Bio

Biotech/Healthcare

Hongyun Biotech is a biotechnology company focused on developing new drugs against targets associated with tumor drug resistance. By leveraging research platforms at leading domestic research institutions, it seeks to address tumor resistance and develop innovative drugs protected by global patents.

Latest round: Series B Extension (2023)

Source: ChinaBulls — chinabulls.com

Last updated 2023-05-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.